- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-03-0254560

Mytanfarma Consultants Private Limited
About Mytanfarma Consultants Private Limited
Data last updated:
Mytanfarma Consultants Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the service-based operations segment of the services sector. It was incorporated on 16 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U93090KA2018PTC113180. Its GSTIN is 29AALCM8440J1ZW (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Harish Babu Mugudalakshmi Narayana and Nirmalanarayana Gunti.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Vijaya Lakshmi #1163 3rd Cross 80 Feet Rd Prakash Nagar, Bangalore, Karnataka, India – 560021.
As per the financials filed for FY 2024, the company reported a revenue of ₹94.55 Lakh, a decline of 53% compared to the previous year. For the same year it recorded a net profit of ₹5.39 Lakh (net margin 5.7%) and EBITDA of ₹21.41 Lakh (EBITDA margin 22.6%). Revenue has grown at a compounded annual rate (CAGR) of 81% over three years.
As per MCA filings, the company has open charges of ₹40.33 Lakh on record.
Mytanfarma Consultants Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0254560).
Company details
Recognitions & Rankings of Mytanfarma Consultants
Contact details
Mytanfarma Consultants Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressVijaya Lakshmi #1163 3rd Cross 80 Feet Rd Prakash Nagar, Bangalore, Karnataka, India – 560021
- IndustryService, Other Services
To see the full contact details of Mytanfarma Consultants Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mytanfarma Consultants is real estate. In detail, this covers real estate activities on fee or contract basis.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| L | Real Estate | L2 | Real estate activities on fee or contract basis |
To see the full business activity and turnover split of Mytanfarma Consultants Private Limited, buy the company report.
Financials of Mytanfarma Consultants Private Limited
FY 2025 filings availableMytanfarma Consultants Private Limited reported revenue of ₹94.55 Lakh (down 53% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 53% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 81%. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21.41 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.39 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.6% | ||||
| Net Profit Margin | 5.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mytanfarma Consultants Private Limited, buy the company report.
Board of directors of Mytanfarma Consultants Private Limited
Mytanfarma Consultants has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harish Babu Mugudalakshmi Narayana | Director | 16 May 2018 | 8 Years 5 Months | Current |
| Nirmalanarayana Gunti | Director | 16 May 2018 | 8 Years 5 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Nov 2023 | 100914032 | Hdfc Bank Limited | ₹14.65 Lakh | Open | |
| 20 Jun 2023 | 100794769 | Hdfc Bank Limited | ₹25.68 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Mytanfarma Consultants Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mytanfarma Consultants Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mytanfarma Consultants has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AALCM8440J1ZW | Karnataka | Active | 17 Jul 2020 |
To see the full GST registrations and return filing status of Mytanfarma Consultants Private Limited, buy the company report.
Recent activity
Mytanfarma Consultants Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Harish Babu Mugudalakshmi Narayana was appointed as Director on 16 May 2018.
Frequently asked questions
Mytanfarma Consultants is an active private limited company based in Bangalore, Karnataka, India. The company works in other services, within the service industry. It was incorporated on 16 May 2018 (8+ years old) and is registered under CIN U93090KA2018PTC113180.
Mytanfarma Consultants has 2 current directors:
- Harish Babu Mugudalakshmi Narayana - Director
- Nirmalanarayana Gunti - Director
The latest financial statements of Mytanfarma Consultants on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Mytanfarma Consultants is 29AALCM8440J1ZW, registered in Karnataka.
The CIN (Corporate Identification Number) of Mytanfarma Consultants is U93090KA2018PTC113180. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mytanfarma Consultants was incorporated on 16 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
Harish Babu Mugudalakshmi Narayana was appointed as Director on 16 May 2018. Nirmalanarayana Gunti was appointed as Director on 16 May 2018.
Yes, Mytanfarma Consultants is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0254560).
The registered office of Mytanfarma Consultants is at Vijaya Lakshmi #1163 3rd Cross 80 Feet Rd Prakash Nagar, Bangalore, Karnataka, India – 560021.
Mytanfarma Consultants operates in the service industry, in the other services segment.

